FEMY Femasys Inc. - Common Stock

NASDAQ · Health Care · View on SEC EDGAR ↗
$3.10
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026

FEMY Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$3.10
Market Cap
$9M
P/E (TTM)
-0.3
EPS (TTM)
$-0.47
Revenue (TTM)
$2M
Div Yield
ROE
-505.0%
Debt/Equity
52W Range
$0 – $8

FEMY Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $2M
6-point trend, +121.0%
2020-12-31 2025-12-31
EPS $-0.47
6-point trend, +93.5%
2020-12-31 2025-12-31
Free Cash Flow $-19M
4-point trend, -133.3%
2021-12-31 2025-12-31
Margins -812.3%
2-point trend, -7.6%
2021-12-31 2022-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
FEMY
Peer Median
P/E (TTM)
5-point trend, +64.8%
-0.3
27.5
P/S (TTM)
4-point trend, -61.6%
4.0
11.3
P/B
4-point trend, +234.6%
1.6
4.0
Price / FCF
4-point trend, +68.0%
-0.5

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
FEMY
Peer Median
Operating Margin
4-point trend, -8.5%
-767.0%
Net Profit Margin
4-point trend, -27.1%
-812.3%
-2016.2%
ROA
4-point trend, -169.5%
-112.3%
-116.3%
ROE
4-point trend, -1741.9%
-505.0%
-195.7%
ROIC
4-point trend, -852.6%
-299.7%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
FEMY
Peer Median
Current Ratio
4-point trend, -70.1%
4.5
3.5
Quick Ratio
4-point trend, -81.5%
2.7

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
FEMY
Peer Median
Revenue YoY
5-point trend, +94.4%
40.8%
Revenue CAGR 3Y
5-point trend, +94.4%
23.9%
Revenue CAGR 5Y
5-point trend, +94.4%
17.2%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
FEMY
Peer Median
EPS (Diluted)
5-point trend, +58.0%
$-0.47

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
FEMY
Peer Median

FEMY Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 9 analysts
  • Strong Buy 2 22.2%
  • Buy 6 66.7%
  • Hold 1 11.1%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

3 analysts · 2026-08-16
Median target $30.00 +868.8%
Mean target $56.67 +1730.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.58%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-1.20 $-1.84 0.64%
Dec. 31, 2025 $-0.20 $-1.78 1.6%
Sept. 30, 2025 $-2.00 $-2.65 0.65%
June 30, 2025 $-3.00 $-3.67 0.67%
March 31, 2025 $-0.23 $-0.19 -0.04%
Dec. 31, 2024 $-0.23 $-0.19 -0.04%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
FEMY $34M -1.2 40.8% -812.3% -505.0%
HSCS
NVNO $210.6K -0.0 -64.7%
NXL $11M -1.1 78.8% -2725.8% -169.3% 79.7%
INBS $13M -0.9 -1.9% -346.2% -186.6% 40.8%
AMIX
NDRA $5M -0.5 -376.5%
BMRA -1.4 -1.9%
ABT $250.18B 33.7 5.7% 14.7% 13.1%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 18
Annual Income Statement data for FEMY
Metric Trend 202520242023202220212020
Revenue 6-point trend, +121.0% $2M $2M $1M $1M $1M $1M
Cost of Revenue 6-point trend, +184.6% $872.4K $544.9K $380.1K $441.9K $370.4K $306.5K
Gross Profit 3-point trend, +4.5% · · · $764.3K $809.3K $731.4K
R&D Expense 6-point trend, +83.5% $8M $8M $7M $6M $4M $4M
SG&A Expense 6-point trend, +161.2% $7M $6M $7M $5M $4M $3M
Operating Expenses 6-point trend, +148.0% $19M $19M $15M $12M $9M $8M
Operating Income 6-point trend, -153.7% $-18M $-18M $-15M $-12M $-8M $-7M
Interest Expense 4-point trend, +1217.5% · · $165.4K $13.5K $19.2K $12.6K
Interest Income 3-point trend, -76.4% $101.8K $582.4K $431.0K · · ·
Other Non-op 6-point trend, -2518.7% $-482.6K $0 $265.6K $212.4K $803.0K $20.0K
Pretax Income 6-point trend, -169.4% $-19M $-19M $-14M $-11M $-8M $-7M
Income Tax 6-point trend, -27.9% $1.3K $9.6K $4.3K $6.3K $4.0K $1.8K
Net Income 6-point trend, -169.4% $-19M $-19M $-14M $-11M $-8M $-7M
EPS (Basic) 6-point trend, +93.5% $-0.47 $-0.85 $-0.93 $-0.96 $-1.12 $-7.20
EPS (Diluted) 6-point trend, +93.5% $-0.47 $-0.85 $-0.93 $-0.96 $-1.12 $-7.20
Shares (Basic) 6-point trend, +4020.3% 39,549,218 22,267,695 15,384,376 11,815,019 6,712,028 959,862
Shares (Diluted) 6-point trend, +4020.3% 39,549,218 22,267,695 15,384,376 11,815,019 6,712,028 959,862
EBITDA 4-point trend, -111.0% $-18M $-18M · $-12M $-8M ·
Balance Sheet 27
Annual Balance Sheet data for FEMY
Metric Trend 202520242023202220212020
Cash & Equivalents 6-point trend, +178.9% $9M $3M $22M $13M $25M $3M
Receivables 6-point trend, +390.2% $616.6K $488.4K $98.9K $77.5K $84.3K $125.8K
Inventory 6-point trend, +4269.3% $6M $3M $667.1K $436.7K $208.3K $131.4K
Other Current Assets 6-point trend, +193.2% $833.1K $1M $695.9K $655.4K $555.9K $284.1K
Current Assets 6-point trend, +325.9% $16M $8M $23M $14M $26M $4M
PP&E (Net) 6-point trend, +3.7% $2M $2M $1M $1M $2M $2M
PP&E (Gross) 6-point trend, +41.6% $6M $5M $5M $5M $4M $4M
Accum. Depreciation 6-point trend, +73.0% $4M $4M $4M $3M $3M $2M
Intangibles 6-point trend, +107.3% $134.9K $65.9K $0 $3.3K $25.1K $65.1K
Other Non-current Assets 6-point trend, +18.7% $940.2K $955.0K $1M $958.2K $655.4K $792.4K
Total Assets 6-point trend, +172.5% $21M $12M $28M $17M $29M $8M
Accounts Payable 6-point trend, +171.4% $2M $1M $1M $510.8K $445.5K $674.3K
Accrued Liabilities 6-point trend, +13.3% $1M $1M $1M $456.7K $603.8K $1M
Short-term Debt 5-point trend, -100.0% · $0 $0 $141.3K $181.1K $630.0K
Current Liabilities 6-point trend, +25.9% $4M $9M $3M $2M $2M $3M
Capital Leases 6-point trend, +33.9% $1M $2M $2M $28.6K $386.2K $769.8K
Other Non-current Liabilities 2-point trend, -100.0% · · · · $0 $32.9K
Total Liabilities 6-point trend, +264.2% $15M $10M $9M $2M $2M $4M
Total Debt 2-point trend, -22.0% · · · $141.3K $181.1K ·
Common Stock 6-point trend, +169.0% $3.0K $23.5K $21.8K $12.0K $11.9K $1.1K
Paid-in Capital 6-point trend, +544.7% $147M $128M $124M $109M $108M $23M
Retained Earnings 6-point trend, -93.9% $-146M $-127M $-108M $-94M $-83M $-75M
Treasury Stock Flat — no change across 6 periods $60.0K $60.0K $60.0K $60.0K $60.0K $60.0K
AOCI Flat — no change across 2 periods · · · · $0 $0
Stockholders' Equity 6-point trend, +111.3% $6M $2M $18M $15M $26M $-52M
Liabilities + Equity 6-point trend, +172.5% $21M $12M $28M $17M $29M $8M
Shares Outstanding 6-point trend, +200.1% 2,980,254 23,355,926 21,657,381 11,869,704 11,804,165 993,124
Cash Flow 14
Annual Cash Flow data for FEMY
Metric Trend 202520242023202220212020
D&A 6-point trend, -49.7% $342.0K $297.3K $483.5K $561.2K $591.1K $679.7K
Stock-based Comp 6-point trend, +148.0% $790.1K $444.1K $675.7K $224.9K $193.4K $318.6K
Deferred Tax 5-point trend, -108.3% $-4M $0 $0 $0 $-2M ·
Amort. of Intangibles 6-point trend, -61.1% $46.2K $20.1K $3.3K $21.8K $40.0K $118.9K
Operating Cash Flow 6-point trend, -278.9% $-19M $-19M $-11M $-11M $-8M $-5M
CapEx 6-point trend, +6186.0% $525.0K $761.7K $143.9K $407.5K $306.9K $8.4K
Investing Cash Flow 6-point trend, -165.1% $-630.1K $-847.8K $-143.9K $-407.5K $-306.9K $968.3K
Stock Issued 5-point trend, +1221.9% · $2M $8M $59.6K $32M $153.2K
Stock Repurchased 3-point trend, +60753.00 · $60.8K $230.0K $0 · ·
Net Stock Activity 3-point trend, -93.8% · $2M · $79.5K $32M ·
Financing Cash Flow 6-point trend, +2783.6% $25M $2M $20M $-681.6K $30M $871.6K
Taxes Paid 6-point trend, +240.3% $6.8K $5.7K $4.5K $5.0K $800 $2.0K
Free Cash Flow 4-point trend, -133.3% $-19M $-20M · $-11M $-8M ·
Levered FCF 2-point trend, -35.1% · · · $-11M $-8M ·
Profitability 8
Annual Profitability data for FEMY
Metric Trend 202520242023202220212020
Gross Margin 2-point trend, -7.6% · · · 63.4% 68.6% ·
Operating Margin 4-point trend, -8.5% -767.0% -1091.8% · -961.7% -706.7% ·
Net Margin 4-point trend, -27.1% -812.3% -1155.0% · -944.6% -639.0% ·
Pretax Margin 4-point trend, -27.2% -812.2% -1154.4% · -944.1% -638.6% ·
EBITDA Margin 4-point trend, -8.5% -767.0% -1091.8% · -961.7% -706.7% ·
ROA 4-point trend, -169.5% -112.3% -93.6% · -50.1% -41.7% ·
ROE 4-point trend, -1741.9% -505.0% -454.8% · -68.5% -27.4% ·
ROIC 4-point trend, -852.6% -299.7% -772.2% · -75.4% -31.5% ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for FEMY
Metric Trend 202520242023202220212020
Current Ratio 4-point trend, -70.1% 4.5 0.9 · 9.2 15.1 ·
Quick Ratio 4-point trend, -81.5% 2.7 0.5 · 8.5 14.7 ·
Debt / Equity 2-point trend, +34.8% · · · 0.0 0.0 ·
Interest Coverage 2-point trend, -98.7% · · · -861.6 -433.6 ·
Efficiency 3
Annual Efficiency data for FEMY
Metric Trend 202520242023202220212020
Asset Turnover 4-point trend, +112.1% 0.1 0.1 · 0.1 0.1 ·
Inventory Turnover 4-point trend, -90.9% 0.2 0.3 · 1.4 2.2 ·
Receivables Turnover 4-point trend, -63.0% 4.2 5.5 · 14.9 11.2 ·
Per Share 5
Annual Per Share data for FEMY
Metric Trend 202520242023202220212020
Book Value / Share 4-point trend, -95.6% $0.10 $0.10 · $1.28 $2.23 ·
Revenue / Share 4-point trend, -67.0% $0.06 $0.07 · $0.10 $0.18 ·
Cash Flow / Share 4-point trend, +60.0% $-0.47 $-0.87 · $-0.91 $-1.18 ·
Cash / Share 4-point trend, -92.6% $0.16 $0.15 · $1.09 $2.10 ·
EPS (TTM) 5-point trend, +58.0% $-0.47 $-0.85 $-0.93 $-0.96 $-1.12 ·
Growth Rates 3
Annual Growth Rates data for FEMY
Metric Trend 202520242023202220212020
Revenue YoY 5-point trend, +198.5% 40.8% 52.0% -11.1% 2.2% 13.7% ·
Revenue CAGR 3Y 3-point trend, +2111.1% 23.9% 11.4% 1.1% · · ·
Revenue CAGR 5Y 17.2% · · · · ·
Valuation (TTM) 14
Annual Valuation (TTM) data for FEMY
Metric Trend 202520242023202220212020
Revenue TTM 5-point trend, +94.4% $2M $2M $1M $1M $1M ·
Net Income TTM 5-point trend, -147.1% $-19M $-19M $-14M $-11M $-8M ·
Market Cap 4-point trend, -25.4% $34M $26M · $11M $46M ·
Enterprise Value 2-point trend, -110.0% · · · $-2M $21M ·
P/E 5-point trend, +64.8% -1.2 -1.3 -1.0 -0.9 -3.5 ·
P/S 4-point trend, -61.6% 15.0 15.8 · 8.9 39.0 ·
P/B 4-point trend, +234.6% 5.8 11.1 · 0.7 1.7 ·
P / Tangible Book 5-point trend, +242.1% 6.0 11.5 1.2 0.7 1.7 ·
P / Cash Flow 4-point trend, +68.4% -1.8 -1.3 · -1.0 -5.8 ·
P / FCF 4-point trend, +68.0% -1.8 -1.3 · -1.0 -5.6 ·
EV / EBITDA 2-point trend, +107.2% · · · 0.2 -2.6 ·
EV / FCF 2-point trend, +107.4% · · · 0.2 -2.6 ·
EV / Revenue 2-point trend, -109.8% · · · -1.8 18.2 ·
Earnings Yield 5-point trend, -184.1% -81.6% -77.3% -95.4% -106.7% -28.7% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $2M$2M$1M$1M$1M
Gross Margin % 63.4%68.6%
Operating Margin % -767.0%-1091.8%-961.7%-706.7%
Net Income $-19M$-19M$-14M$-11M$-8M
Diluted EPS $-0.47$-0.85$-0.93$-0.96$-1.12
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.00.0
Current Ratio 4.50.99.215.1
Quick Ratio 2.70.58.514.7
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-19M$-20M$-11M$-8M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 4 filers · $680K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
0 33 0 1

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $671,431 1,165,679 98.68% Shares
Pandora Wealth, Inc. $8,643 15,000 1.27% Shares
IFP Advisors, Inc $306 1,000 0.04% Shares
CX Institutional $3 750 0.00% Shares

Company insiders 20 insiders · 4 officers · 7 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Daniel Scott Currie Chief Operating Officer June 2, 2025 I 86,275 0 0 $0
Kelley Stinson Nicholas Chief Commercial Officer June 23, 2025 A 0 0 $0
Christine E Thomas Chief Reg & Clinical Officer Jan. 28, 2025 A 0 0 $0
Richard D. Spector Chief Commercial Officer Feb. 12, 2024 A 0 0 $0
Joshua Silverman Director June 25, 2025 A 0 0 $0
Anne Morrissey Director June 21, 2023 A 0 0 $0
Wendy Perrow Director June 21, 2023 A 0 0 $0
Keith J Kendall Director June 14, 2023 A 0 0 $0
John Q Adams JR Director June 8, 2022 A 239,938 0 0 $0
John Dyett Director June 8, 2022 A 114,709 0 0 $0
William Benson Witte Director Dec. 15, 2021 J 12,191 0 0 $0
Jeffrey Gerald Mifek Aug. 7, 2026 A 3,125 1 0 $10,000
John Charles Canning Aug. 7, 2026 A 4,375 1 0 $14,000
Jeremy Alexander Sipos Aug. 7, 2026 A 3,125 1 0 $10,000
Kathy Lee-Sepsick Aug. 7, 2026 A 15,625 1 0 $50,000
Dov Elefant Aug. 7, 2026 A 15,625 1 0 $50,000
Kenneth D. Eichenbaum June 24, 2026 A 0 0 $0
Alistair Milnes June 24, 2026 A 0 0 $0
Charles Larsen June 24, 2026 A 56 0 0 $0
Edward R Uzialko June 24, 2026 A 30,175 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 2 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Nantahala Capital Partners Limited Partnership, Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack Aug. 17, 2026 9.99% Initial filing Passive investment SEC
PharmaCyte Biotech, Inc. Nov. 22, 2023 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 2 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 27,936 SH Aug. 8, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 34,296 SH Aug. 8, 2026 Daily